HIGHLIGHTS
- who: Report and collaborators from the Internal Medicine, Mayo Clinic, Jacksonville, USA have published the Article: Review began 03/02/2023 Review ended 03/10/2023 Published 03/14/2023 u00a9 Copyright, in the Journal: (JOURNAL) of March/14,/2023
- what: ANKRD26-related thrombocytopenia is a rare genetic disorder that can increase the risk of developing AML.
SUMMARY
ANKRD26-related thrombocytopenia is a rare genetic disorder that affects platelet production and is associated with an increased risk of developing acute myeloid leukemia (AML). Pathogenic variants reported in ANKRD26 are found in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.